Immunomagnetic Multiplexing

Each particle population carries antibodies directed toward a defined antigen or cell-surface marker, while its code identifies the capture population. Detection labels provide an additional signal for recognizing the bound target. Together, these identifiers let an assay associate a captured biological target with the correct particle type, allowing multiple measurements to be interpreted in parallel rather than as unrelated single-target tests.

The magnetic field concentrates or separates antibody-particle-target complexes from the surrounding sample. This physical handling complements antibody selectivity: binding determines what is recognized, while magnetic manipulation helps recover or organize the resulting complexes. In complex medical samples, that combination can make captured material easier to analyze and can support processing of several target types within the same experimental workflow.

Selective recognition assigns different biological targets to defined antibody-particle interactions. That organization is essential in a multiplex format because several antigens or cell-surface markers may be present simultaneously. When recognition is paired with distinct particle codes or detection labels, the resulting signals can be linked to particular targets, supporting parallel characterization instead of an undifferentiated measurement from the whole sample.

A typical workflow begins with antibody-coated magnetic particles designed for the selected antigens or cell-surface markers. The particles are then used with a biological sample so target binding can occur, followed by application of a magnetic field to concentrate or separate the complexes. Finally, particle codes or detection labels are read to identify the captured targets and characterize the sample.

The approach is useful when medical analysis requires concentrating rare cells from a more complex sample. Antibodies directed at cell-surface markers provide the recognition step, and magnetic handling supports separation or concentration of the resulting cell-particle complexes. This can make scarce cellular populations more accessible for downstream characterization, especially when the available sample is limited or contains many other components.

For pathogen detection, antibody-particle interactions can capture defined biological targets and magnetic handling can concentrate the associated complexes for identification. In biomarker profiling, multiple antigens can be assessed in parallel using distinct particle codes or detection labels. These applications help medical investigations examine several indicators from one complex or limited sample, supporting broader characterization of disease states than a single-target measurement.